RAD51AP1 is overexpressed in breast cancer stem cells population (BCSCs) and its knockout/down reduced cancer stem cells population in breast, lung, and colon cancer mouse models and improved chemotherapy and radiotherapy [68,69]. Here, RAD51AP1 is linked to breast cancer.